The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration. [electronic resource]
Producer: 20181211Description: 298 p. digitalISSN:- 1471-2415
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Biomarkers
- Female
- Humans
- Macular Degeneration -- drug therapy
- Male
- Middle Aged
- Prevalence
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retina -- pathology
- Retreatment
- Retrospective Studies
- Visual Acuity
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.